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Granulocytic sarcoma is a rare extramedullary tumour, which most often occurs in the course of an acute or chronic leukaemia or
myeloproliferative disorders. Rarely it is foundbefore peripheral blood or bone marrowevidence of leukemiaispresent. Wereport
an unusual case of acute paraplegia at ﬁrst presentation of a spinal epidural granulocytic sarcoma without any haematological
disorder. Therapeutic strategies are discussed in the light of the literature.
1.Introduction
Granulocytic sarcoma is a rare extramedullary tumour
composed of immature cells of the granulocytic series [1].
Most cases of granulocytic sarcoma occur in the course of an
acute or chronic leukaemia or myeloproliferative disorders.
It is rarely found before evidence of leukemia. Spinal cord
invasion by granulocytic sarcoma is also uncommon [2].
We report an unusual case of acute paraplegia at ﬁrst pre-
sentation of a spinal epidural granulocytic sarcoma without
any haematological disorder and treated with association of
neurosurgery and radiation.
2.CaseReport
A previously healthy 41-year-old man was hospitalized for
acute paraplegia. Four weeks before, he had developed a
localized back pain and gradual weakness of both legs.
Physical examination revealed complete paralysis of left
lower extremity, 1/5 paraparesis of right lower extremity,
symmetric severe hypoesthesia with supraumbilical sensitive
level, reduced deep tendon reﬂexes in the lower extremities,
and loss of sphincter tone. Cutaneous plantar reﬂexes were
both with ﬂexion. Laboratory evaluation revealed a white
blood cell count of 12800/mm3, a haemoglobin level of
11.6g/dL, and a platelet count of 327000/mm3.
Magnetic resonance imaging (MRI) of the thoracolum-
bar spine revealed an anterior and circular epidural mass of
T8 with spinal block(Figures 1 and 2). He received highdose
of corticosteroids and underwent emergency decompressive
laminectomies of T7 and T8.
Anatomopathologic observations revealed a population
of immature large cells with ovale and slightly nuclei
and eosinophilic cytoplasm. Immunohistochemical staining
revealed the strong expression of myeloperoxidase (MPO)
in 30% of tumour cells, weaker expression of MPO in the
same rate of cells, strong positivity of macrophages for
CD68,strong positivity ofneutrophilpolynuclearsforCD15,
and positivity of vascular structures for CD34. The tumor
cells proliferation was negative for B-lymphoid markers
(CD20, CD79a, Mi18) and T markers (CD1a, CD3, CD5).
Ki 67 evaluation was of 80% of the tumor cells. Altogether,
these phenotypic and anatomic features sustained the diag-
nosis of granulocytic sarcoma.Two medullograms revealed
neither morphologic abnormalities, nor excess of blasts.
Bone marrow examination showed slightly granulocytic
hyperplasia but neither leukemic inﬁltration nor evidence of
myelodysplasia.
I nt h ee a r l yp o s t o p e r a t i v ep e r i o d ,t h ep a t i e n ts h o w e df a s t
recovery of paraplegia but persistent partial hypoesthesia.
Furthermore, there was in a few days an improvement
of sphincter abnormalities and pain disappeared. Spinal2 Case Reports in Medicine
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Figure 1: Magnetic resonance imaging of the thoracolumbar spine revealing an anterior and circular epidural mass of T8 (axial view).
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Figure 2: Magnetic resonance imaging of the thoracolumbar spine revealing an anterior and circular epidural mass of T8 (sagittalview).
radiotherapy (RT) of 40Gy to the thoracic spine was
delivered 15 days after surgery from T5 to T10, given in 16
fractions, with no acute toxicity.
Unfortunately, after one-year followup, the patient has
developed an acute AML-4 (acute myeloid leukaemia type
4) with chromosome 16 inversion. He was referred for high
doses of idarubicine and aracytine as ﬁrst line chemotherapy
(CT).
3.Discussion
Also known as chloroma by the green colour the myeloper-
o x i d a s ee n z y m eg i v e so ﬀ, granulocytic sarcoma is a rare
tumor that is composed of immature granulocytes in
extramedullary sites. It usually presents concomitantly
with or in the course of acute myelogenous leukaemia
(AML), blastic phase of chronic myelogenous leukaemia, or
myelodysplastic syndrome [1, 2]. Granulocytic sarcoma is
reported in 0.7–9 per cent of patients with acute or chronic
myelogenous leukaemia [3]. Most of them are children
or young adults. Their survival is shorter than that of
patients without granulocytic sarcoma. Granulocytic sar-
coma preceding the evidence of leukaemia is very rare. It
is reported to occur in 0.6% of AML [4]. In nearly half of
cases without any haematological disorder, acute leukaemia
develops in a short delay, since the mean interval between
initial diagnosis and the onset of acute leukaemia is about 10
months [2].Duetorarityand becausemorphologicevidence
of granulocytic diﬀerentiation is frequently lacking, about
75% ofnonleukemicgranulocytic sarcoma are misdiagnosed
as other common malignancies, as lymphoma (50%) or
nonhematopoietic neoplasm (25%) [5]. It should be noticed
that the green colour rapidly fades when exposed to air,
which contributes to misdiagnosing granulocytic sarcoma
[6].
Granulocytic sarcomas usually occur in the bone, skin,
and lymph nodes. While bony involvement is most common
in the orbit, sacrum, spine, or ribes, presentation as an
epidural granulocytic sarcoma with cord compression in
aleukemic patients is extremely rare. We could ﬁnd only 15
such cases described in the literature. The most frequentCase Reports in Medicine 3
initial symptoms of paraspinal granulocytic sarcoma were
back pain and radicular pain. Weakness and/or paralysis
of one or more extremities were reported in approximately
80%,with the thoracic level being the most commonly
aﬀected site.
Nonleukemic granulocytic sarcoma represents a thera-
peutic dilemma because the optimal therapy is unclear [7].
More than 80% of patients with nonleukemic granulocytic
sarcoma who are treated by local therapy alone (either
surgical excision or RT or both therapies) will develop overt
leukaemia in a few months following local treatment [4, 8].
A retrospective Canadian study of 90 cases of nonleukemic
granulocytic sarcoma [9] provided further evidence of
systemic therapy early in the course of nonleukemic gran-
ulocytic sarcoma, with a decreased probability of developing
AML if receiving CT (41% versus 71%, P = .001). Moreover,
themediantimefromdiagnosisofnonleukemicgranulocytic
sarcoma to leukaemia was 36 months for patients treated
with CT (versus 6 months in untreated patients). Overall
survival was twice longer in the patients receiving CT
than for patients who did not (median survival of 25
months if treated with CT versus 13 months in patients
untreated). This study showed that the local treatment alone
had no eﬀect on survival. Another retrospective study of
74 cases [10] showed that the nonleukemic period after
the diagnosis of granulocytic sarcoma was 12 months for
patients receiving antileukemic induction CT versus 3 and
6 months for patients receiving only surgical resection or RT,
respectively. Impact of allogenic or autologous bone marrow
transplantation has not been deﬁned.
In case of spinal cord compression in a leukemic patient,
treatment of choice is to deliver RT and CT before surgery.
However, the optimal management of paraspinal granulo-
cytic sarcoma in nonleukemic patients is more controversial.
For nonleukemic patients without radiological or clinical
evidence of cord compression, granulocytic sarcoma should
be primarily treated with high dose of corticosteroids
followed by systemic AML type CT and RT considering the
high chemo- and/or radiosensitivity of the tumour [6].
For aleukemic patients with rapidly progressive neuro-
logical signs and radiological evidence of cord compression
(as in the case we reported here), emergency laminectomy
couldbelogicallyrecommended[11].Consideringtheriskof
subsequent leukaemia and the poor outcome after only local
treatment, early postoperative systemic AML-type CT seems
reasonable. Considering the high risk of subsequent devel-
opment of overt leukaemia, radiation therapy alone does
not seem to be enough, and it was suggested that patients
with isolated granulocytic sarcoma should be treated, after
local treatment, as if they had acute myelogenous leukaemia.
However, the beneﬁt of delivering CT (which is a associated
with high rate of severe treatment-related toxicities) has
not been prospectively demonstrated. Further assessments
are therefore encouraged, but large randomized trials will
not be possible, due to the disease rarity. In the last
guidelines published by the National Comprehensive Cancer
Network, it was recommended that for patients presenting
with solitary extramedullary disease without overt marrow
disease, theinitialtreatment should stillbebased onsystemic
chemotherapy. Radiation therapy or surgical procedure
would be incorporated in case of emergency situation [12].
For elderly patients, another strategy could be to treat
locally granulocytic sarcoma, then treat systematically when
AML develops, typically within one to three years. Anyway,
the decision of treating systematically patients before the
evidence of AML should be taken after multidisciplinary
discussion, since about 20% of nonleukemic patients will
remain disease-free after local therapy only.
4.Conclusion
Granulocytic sarcomas are rarely observed before the diag-
nosis of any hematological malignancy. Frequently misdi-
agnosed, most of them are harbingers of acute leukaemia
developing in next few months. Early diagnosis may allow
patientsaﬀectedtobemoreeﬃcientlytreated andpotentially
increasing their survival. Presentation as an epidural granu-
locytic sarcoma and cord compression in leukemic patients
is extremely rare and requires emergency laminectomy with
postoperative RT when neurological symptoms are present.
Although systemic antileukemic CT seems to be a promising
strategy, the beneﬁt of such strategy needs to be further
assessed.
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